A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 63
[Display Entries]
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : NCVs
Long Form : nerve conduction velocities
No. Year Title Co-occurring Abbreviation
2021 Nerve conduit based on HAP/PDLLA/PRGD for peripheral nerve regeneration with sustained release of valproic acid. CMAPs, PDLLA, VPA
2020 Cardiometabolic risk factors as determinants of peripheral nerve function: the Maastricht Study. VPT
2020 Efficacy and Safety of Mecobalamin on Peripheral Neuropathy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. CI, RR
2020 Exogenous neuritin treatment improves survivability and functions of Schwann cells with improved outgrowth of neurons in rat diabetic neuropathy. ---
2020 Troponin T Parallels Structural Nerve Damage in Type 2 Diabetes: A Cross-sectional Study Using Magnetic Resonance Neurography. DN, FA, hs-TnT, MRN, T2D
2018 Chronic kidney disease and peripheral nerve function in the Health, Aging and Body Composition Study. CI, CKD, CMAPs, OR
2018 Fasudil combined with methylcobalamin or lipoic acid can improve the nerve conduction velocity in patients with diabetic peripheral neuropathy: A meta-analysis. CI, DPN, MD, RCTs, RR, SNCV
2018 Global Transcriptomic Profile of Dorsal Root Ganglion and Physiological Correlates of Cisplatin-Induced Peripheral Neuropathy. DRG, WDR
2018 Low serum bilirubin levels contribute to the presence and progression of distal symmetrical polyneuropathy in Chinese patients with type 2 diabetes. DSPN, T2D
10  2017 Adult-onset demyelinating neuropathy associated with FBLN5 gene mutation. AD-CMT, CMAP, FBLN5
11  2017 Can both normal and mildly abnormal albuminuria and glomerular filtration rate be a danger signal for diabetic peripheral neuropathy in type 2 diabetes mellitus? AUC, DPN, eGFR, ROC, UACR
12  2016 Clinical, electrophysiological, and biochemical markers of peripheral and central nervous system disease in canine globoid cell leukodystrophy (Krabbe'sdisease). GALC, GLD
13  2016 Neuroradiological, neurophysiological and molecular findings in infantile Krabbe disease: two case reports. beta-GALC, MRI
14  2015 Bone Marrow-Derived Mesenchymal Stem Cells Improve Diabetic Neuropathy by Direct Modulation of Both Angiogenesis and Myelination in Peripheral Nerves. BM-MSCs, DN, MSCs, STZ
15  2015 Effects of prostaglandin E1 plus methylcobalamin alone and in combination with lipoic acid on nerve conduction velocity in patients with diabetic peripheral neuropathy: A meta-analysis. CI, DPN, MD, RCTs, RRs
16  2014 Meta-analysis of methylcobalamin alone and in combination with prostaglandin E1 in the treatment of diabetic peripheral neuropathy. CI, DPN, MC, MNCV, PGE1-MC, RCTs, RR, SNCV
17  2014 Peripheral neuropathy: detection with diffusion-tensor imaging. DTI, FA
18  2014 Ranolazine attenuates mechanical allodynia associated with demyelination injury. ---
19  2013 Evaluation of spectrum of peripheral neuropathy in predialysis patients with chronic kidney disease. ---
20  2012 Evaluation of upper extremity nerve conduction velocities and the relationship between fibromyalgia and carpal tunnel syndrome. CTS, DL, FS
21  2011 Electrophysiologic evidence of spinal accessory neuropathy in patients with cervical myofascial pain syndrome. CMAPs, MCDs, MFPS, NCSs
22  2011 Interleukin-10 and regeneration in an end-to-side nerve repair model of the rat. ETS, IL-10
23  2011 PDLLA/chondroitin sulfate/chitosan/NGF conduits for peripheral nerve regeneration. NGF, SD
24  2009 Bone marrow mononuclear cells have neurovascular tropism and improve diabetic neuropathy. BMNCs, DN
25  2009 Elevated triglycerides correlate with progression of diabetic neuropathy. MFD
26  2007 Arsenic metabolites affect expression of the neurofilament and tau genes: an in-vitro study into the mechanism of arsenic neurotoxicity. MAPT, NEFH, NEFL, PNS
27  2007 Arsenic-induced toxicity: effect on protein composition in sciatic nerve. PNS
28  2007 Chondrotinase ABC enhances axonal regeneration across nerve gaps. CMAPs
29  2006 Nerve conduction study among healthy malays. The influence of age, height and body mass index on median, ulnar, common peroneal and sural nerves. BMI
30  2005 Characterization of genetically defined types of Charcot-Marie-Tooth neuropathies by using magnetic resonance neurography. CMT, MR
31  2005 Clinical disease severity and axonal dysfunction in hereditary motor and sensory neuropathy Ia. CMAP/SNAP, HMSN Ia
32  2005 Conduction velocity distribution in neurologically well-recovered but fatigued Guillain-Barre syndrome patients. CIDP, CVD, GBS
33  2005 Nerve conduction studies in chronic arsenic poisoning patients. ---
34  2004 C-peptide corrects endoneurial blood flow but not oxidative stress in type 1 BB/Wor rats. EDN, NO, ZDR
35  2004 EMG and nerve conduction studies in children with congenital muscular dystrophy. CMD, EMG
36  2004 Thermal thresholds predict painfulness of diabetic neuropathies. DN, HRV, QST, VASs
37  2003 Early diagnosis of diabetic neuropathy using double-shock stimulation of peripheral nerves. NAP
38  2003 Phenotypic expression of a Pro 87 to Leu mutation in the connexin 32 gene in a large Swiss family with Charcot-Marie-Tooth neuropathy. Cx32
39  2003 Slowed conduction and thin myelination of peripheral nerves associated with mutant rho Guanine-nucleotide exchange factor 10. GEF, HMSN, RhoGTPases
40  2000 Neurological dysfunction and axonal degeneration in Charcot-Marie-Tooth disease type 1A. CMAPs and SNAPs, CMT1A
41  1999 Focal sensory nerve abnormalities in patients with amyotrophic lateral sclerosis. ALS
42  1998 Effects of the peptide HP228 on nerve disorders in diabetic rats. ---
43  1997 Effects of occupational use of vibrating tools in the autonomic, central and peripheral nervous system. DCV, SSEP
44  1997 Evoked potential study in facio-scapulo-humeral muscular dystrophy. FSHD
45  1996 A cross-sectional study on nerve conduction velocities among workers exposed to carbon disulphide. ---
46  1996 Duplication of the PMP22 gene in 17p partial trisomy patients with Charcot-Marie-Tooth type-1 neuropathy. CMT1A, FISH
47  1996 Nerve conduction velocity and H-reflex recovery in bipolar illness. ---
48  1996 The efficacy of tolrestat in the treatment of diabetic peripheral neuropathy. A meta-analysis of individual patient data. ---
49  1995 Dejerine-Sottas disease with de novo dominant point mutation of the PMP22 gene. ---
50  1995 Polyneuropathy induced by carbon disulphide in viscose rayon workers. ---
51  1994 Assessment of exposure to arsenic among smelter workers: a five-year follow-up. ---
52  1993 Sensory nerve conduction velocities are higher on the left than the right hand and motor conduction is faster on the right hand than left in right-handed normal subjects. ---
53  1992 Gene dosage is a mechanism for Charcot-Marie-Tooth disease type 1A. CMT1A
54  1991 AAEM minimonograph #14: The influence of temperature in clinical neurophysiology. SEPs
55  1991 Nerve conduction velocity to different muscles in peroneal pressure neuropathy. NCV
56  1990 Subclinical lithium neurotoxicity: correlation of neural conduction abnormalities and serum lithium level in manic-depressive patients with lithium treatment. ---
57  1989 A comparison of nerve conduction velocities and current perception thresholds as correlates of clinical severity of diabetic sensory neuropathy. CPTs, PS, SS, VTs
58  1989 Prevalence of neuropathy in newly diagnosed NIDDM and nondiabetic control subjects. ---
59  1985 Evolution of nerve conduction velocity in later childhood and adolescence. ---
60  1983 Asymmetric function of peripheral nerves in children with cerebral palsy. NAPs
61  1979 H-reflex latency in uremic neuropathy: correlation with NCV and clinical findings. ---
62  1978 Nerve conduction velocity in hypertensive patients. ---
63  1978 Rapid improvement in nerve conduction velocity following renal transplantation. ---